Results 171 to 180 of about 14,869 (256)

Maternal and Fetal Outcomes in Imiglucerase‐Treated Patients With Gaucher Disease: Real‐World Evidence From the International Collaborative Gaucher Group (ICGG) Gaucher Registry Pregnancy Sub‐Registry

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.
This graphical abstract highlight the real‐world maternal and fetal outcomes in imiglucerase‐treated patients with Gaucher disease from the International Collaborative Gaucher Group (ICGG) Gaucher Registry Pregnancy Sub‐Registry. ABSTRACT Untreated women with Gaucher disease (GD) are at an increased risk of GD‐related complications during pregnancy ...
Shoshana Revel‐Vilk   +8 more
wiley   +1 more source

Safety of Vortioxetine in Patients With Depression: A Post‐Marketing Surveillance Study of Intracranial Hemorrhage in a Japanese Health Insurance Claims Database

open access: yesNeuropsychopharmacology Reports, Volume 46, Issue 1, March 2026.
This real‐world, retrospective cohort study showed that the incidence of intracranial hemorrhage was low in Japanese patients with depression prescribed vortioxetine, and comparable with that observed in patients prescribed selective serotonin reuptake inhibitors (SSRIs).
Takeshi Inoue   +2 more
wiley   +1 more source

Considerations for Menstrual Suppression in Patients With Hematologic Malignancies

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 3, March 2026.
ABSTRACT Patients who menstruate during treatment for hematologic malignancies have a higher risk of heavy vaginal bleeding due to thrombocytopenia caused by malignancy and myelosuppressive chemotherapy. Heavy menstrual bleeding is associated with significant morbidity in this patient population, and menstrual suppression is a standard of supportive ...
Sahaana Veeravalli   +3 more
wiley   +1 more source

Society for Maternal‐Fetal Medicine Consult Series #76: Cancer in pregnancy

open access: yesPregnancy, Volume 2, Issue 2, March 2026.
Abstract Approximately one in 1000 pregnancies is complicated by the diagnosis of cancer each year, and the incidence of cancer among reproductive‐age individuals is increasing. Management of a pregnant person with cancer can be complex and warrants a multidisciplinary approach to care.
Society for Maternal‐Fetal Medicine (SMFM)   +6 more
wiley   +1 more source

Predicting intrauterine vacuum‐induced postpartum hemorrhage‐control device treatment success

open access: yesPregnancy, Volume 2, Issue 2, March 2026.
Abstract Objective To identify predictors of postpartum hemorrhage (PPH) treatment success with the JADA intrauterine vacuum‐induced hemorrhage‐control device in post‐market settings. Methods We performed a retrospective cohort study of PPH managed using the JADA system across 16 centers in the United States (NCT04995887). Treatment success was defined
Marcela C. Smid   +9 more
wiley   +1 more source

Preoperative Hemostatic Management for Refractory Abnormal Uterine Bleeding in Patients With von Willebrand Disease: A Case Report. [PDF]

open access: yesCase Rep Obstet Gynecol
Hiksas R   +5 more
europepmc   +1 more source

Spontaneous preterm birth following unintended hysterotomy extension during second‐stage labor cesarean delivery

open access: yesPregnancy, Volume 2, Issue 2, March 2026.
Abstract Background Unintended hysterotomy extensions occur frequently during second‐stage cesarean delivery and may result in uterine and cervical tissue trauma. The impact of these extensions on adverse outcomes in subsequent pregnancies, including spontaneous preterm birth (sPTB), remains unknown.
Adwoa A. Baffoe‐Bonnie   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy